Epidemiology and health economics
Understanding where the health burden is and whether new vaccines are likely to be cost-effective is essential for the implementation of vaccination programmes. This cross-cutting theme both supports vaccine development and assesses the outcome of vaccine implementation.
- Vaccine-preventable diseases occur all over the world and in many cases may make the greatest impact in developing countries. It is essential that the spread of these infections is understood so that vaccine development can be prioritised appropriately, especially where certain high-risk groups are particularly affected.
- As new vaccines become available, data about disease burden and the predicted benefits of vaccine uptake are necessary to understand whether a vaccine will be effective in the wider population and our ability to provide it to those in need.
Key members of this theme
Dr Victoria Cornelius
/prod01/channel_2/media/migration/research-groups/Cornelius,-Victoria--tojpeg_1510051551176_x4.jpg)
Dr Victoria Cornelius
Senior Lecturer in Clinical Trial Statistics
Professor Andrea Crisanti
/prod01/channel_2/media/migration/research-groups/Crisanti,-Andrea--tojpeg_1510051617588_x4.jpg)
Professor Andrea Crisanti
Professor of Molecular Parasitology
Professor Christl Donnelly
/prod01/channel_2/media/migration/research-groups/Donnelly,-Christl--tojpeg_1510051684538_x4.jpg)
Professor Christl Donnelly
Professor of Statistical Epidemiology
Dr Ilaria Dorigatti
/prod01/channel_2/media/migration/research-groups/Dorigatti,-Ilaria--tojpeg_1510051770501_x4.jpg)
Dr Ilaria Dorigatti
Lecturer/Sir Henry Dale Fellow
Professor Neil Ferguson
/prod01/channel_2/media/migration/research-groups/Ferguson,-Neil--tojpeg_1510053615887_x4.jpg)
Professor Neil Ferguson
Professor of Mathematical Biology and Head of Department
Dr Tini Garske
/prod01/channel_2/media/migration/research-groups/Garske,-Tini--tojpeg_1510053691280_x4.jpg)
Dr Tini Garske
Lecturer in Infectious Disease Analysis
Professor Azra Ghani
/prod01/channel_2/media/migration/research-groups/Ghani,-Azra--tojpeg_1510053827458_x4.jpg)
Professor Azra Ghani
Chair in Infectious Disease Epidemiology
Professor Nicholas Grassly
/prod01/channel_2/media/migration/research-groups/Grassly,-Nicholas--tojpeg_1510053961405_x4.jpg)
Professor Nicholas Grassly
Professor of Infectious Disease & Vaccine Epidemiology
Dr Katharina Hauck
/prod01/channel_2/media/migration/research-groups/Hauck,-Katharina--tojpeg_1510054011935_x4.jpg)
Dr Katharina Hauck
Senior Lecturer in Health Economics
Professor Alison Holmes
/prod01/channel_2/media/migration/research-groups/Holmes,-Alison--tojpeg_1510053143659_x4.jpg)
Professor Alison Holmes
Professor of Infectious Diseases
Dr Natsuko Imai
/prod01/channel_2/media/migration/research-groups/Imai,-Natsuko--tojpeg_1510054094722_x4.jpg)
Dr Natsuko Imai
Research Associate
Krystal Lau
/prod01/channel_2/media/migration/research-groups/Lau,-Krystal--tojpeg_1510054181865_x4.jpg)
Krystal Lau
Research Postgraduate
Dr Marisa Miraldo
/prod01/channel_2/media/migration/research-groups/Miraldo,-Marisa--tojpeg_1510054250538_x4.jpg)
Dr Marisa Miraldo
Associate Professor in Health Economics
Professor Peter Openshaw
/prod01/channel_2/media/migration/research-groups/Openshaw,-Peter--tojpeg_1510053266469_x4.jpg)
Professor Peter Openshaw
Clinical Consul for the Faculty of Medicine
Professor Steven Riley
/prod01/channel_2/media/migration/research-groups/Riley,-Steven--tojpeg_1510054313205_x4.jpg)
Professor Steven Riley
Professor of Infectious Disease Dynamics
Ana Wheelock Zalaquett
/prod01/channel_2/media/migration/research-groups/Wheelock-Zalaquett,-Ana--tojpeg_1510054400557_x4.jpg)
Ana Wheelock Zalaquett
Honorary Research Associate